1. Home
  2. NYXH vs CHPT Comparison

NYXH vs CHPT Comparison

Compare NYXH & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYXH
  • CHPT
  • Stock Information
  • Founded
  • NYXH 2009
  • CHPT 2007
  • Country
  • NYXH Belgium
  • CHPT United States
  • Employees
  • NYXH N/A
  • CHPT N/A
  • Industry
  • NYXH Medical/Dental Instruments
  • CHPT Industrial Specialties
  • Sector
  • NYXH Health Care
  • CHPT Consumer Discretionary
  • Exchange
  • NYXH Nasdaq
  • CHPT Nasdaq
  • Market Cap
  • NYXH 273.3M
  • CHPT 340.1M
  • IPO Year
  • NYXH 2021
  • CHPT N/A
  • Fundamental
  • Price
  • NYXH $7.46
  • CHPT $9.69
  • Analyst Decision
  • NYXH Strong Buy
  • CHPT Hold
  • Analyst Count
  • NYXH 4
  • CHPT 10
  • Target Price
  • NYXH $14.50
  • CHPT $29.13
  • AVG Volume (30 Days)
  • NYXH 49.7K
  • CHPT 1.0M
  • Earning Date
  • NYXH 08-18-2025
  • CHPT 09-03-2025
  • Dividend Yield
  • NYXH N/A
  • CHPT N/A
  • EPS Growth
  • NYXH N/A
  • CHPT N/A
  • EPS
  • NYXH N/A
  • CHPT N/A
  • Revenue
  • NYXH $4,716,818.00
  • CHPT $407,681,000.00
  • Revenue This Year
  • NYXH $209.22
  • CHPT $2.75
  • Revenue Next Year
  • NYXH $219.37
  • CHPT $23.83
  • P/E Ratio
  • NYXH N/A
  • CHPT N/A
  • Revenue Growth
  • NYXH N/A
  • CHPT N/A
  • 52 Week Low
  • NYXH $5.55
  • CHPT $8.55
  • 52 Week High
  • NYXH $11.87
  • CHPT $40.00
  • Technical
  • Relative Strength Index (RSI)
  • NYXH 46.80
  • CHPT 32.39
  • Support Level
  • NYXH $6.90
  • CHPT $12.20
  • Resistance Level
  • NYXH $7.60
  • CHPT $13.60
  • Average True Range (ATR)
  • NYXH 0.34
  • CHPT 1.00
  • MACD
  • NYXH -0.05
  • CHPT -0.22
  • Stochastic Oscillator
  • NYXH 38.10
  • CHPT 21.31

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

About CHPT ChargePoint Holdings Inc.

ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.

Share on Social Networks: